奥泰生物: 监事会关于公司2024年限制性股票激励计划预留授予激励对象的核查意见

Group 1 - The core viewpoint of the article is that Hangzhou Aotai Biotechnology Co., Ltd. has conducted a review of the list of incentive objects for its 2024 restricted stock incentive plan and has confirmed their eligibility according to relevant laws and regulations [1][2] - The incentive objects do not include independent directors, supervisors, shareholders holding more than 5% of the company's shares, actual controllers and their immediate family members, or foreign employees [1][2] - The list of incentive objects for the plan is consistent with the list approved at the company's second extraordinary general meeting in 2024 [1][2] Group 2 - The incentive objects meet the qualifications stipulated by the Company Law, Securities Law, and other relevant regulations, confirming their legal and effective status as incentive recipients [2] - The reserved grant date for the incentive plan is set for August 29, 2025, with a grant price of 26.2993 yuan per share for 188,000 restricted shares to be awarded to 41 eligible incentive objects [2]